Beta Bionics (BBNX) Asset Writedowns and Impairment (2024 - 2025)
Beta Bionics' (BBNX) quarterly Asset Writedowns and Impairment came in at $16000.0 in Q4 2025, down 38.46% year-on-year from $26000.0 in Q4 2024, and down 33.33% quarter-over-quarter from $24000.0 in Q3 2025.
Beta Bionics (BBNX) Asset Writedowns and Impairment (2024 - 2025) Analysis & Trends
Beta Bionics has disclosed Asset Writedowns and Impairment across 2 years of filings, most recently posting $16000.0 for Q4 2025.
- Asset Writedowns and Impairment for Q4 2025 came in at $16000.0, down 38.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $40000.0 (down 42.86% YoY), and the FY2025 annual result was $40000.0, down 42.86% from the prior year.
- Asset Writedowns and Impairment came in at $16000.0 for Q4 2025 at Beta Bionics, down from $24000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $27000.0 in Q2 2024 to a low of $16000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Beta Bionics | 617.66 Mn | 587.36 Mn | 16.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16,000.00 |
| Dec 31, 2025 | 16,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Mar 31, 2024 | 17,000.00 |